Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_837_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
38 Мб
Скачать
40
D. G. Bakes and L. R. Sands
Table 5.2 Duke activity status index
Can you Weight
1. Take care of yourself: eating, dressing, bathing or using the toilet?
2. Walk indoors, such as around your house?
3. Walk a block or two on level ground?
4. Climb a ight of stairs or walk up a hill?
5. Run a short distance? 8.00
6. Do light work around the house like dusting or washing dishes?
7. Do moderate work around the house like vacuuming, sweeping oors, or carrying in groceries?
8. Do heavy work around the house like scrubbing oors or lifting or moving heavy furniture?
9. Do yard work like raking leaves, weeding, or pushing a power mower?
10. Have sexual relations? 5.25
11. Participate in moderate recreational activities like golf, bowling, dancing, doubles tennis, or throwing a baseball or football?
12. Participate in strenuous sports like swimming, singles tennis, football, basketball, or skiing?
Total score: DASI scoring: Positive
2.75
1.75
2.75
5.50
2.70
3.50
8.00
4.50
6.00
7.50
responses are summed to get a total score, which ranges from 0 to 58.2. Higher scores indicate higher functional capacity and lower incidence of MACE.
(apoB). The activity index has greater rele­vance predicting major adverse cardiac events after surgery than biomarkers. However, there are studies suggestive that higher serum lev­els of natriuretic peptides, particularly BNP and N-terminal-pro-BNP, which are secreted by myocardium into the circulation in response to ischemia and stretching of the
heart wall are signicant markers of cardio­vascular risk and complications after non­cardiac surgery. High sensitivity cardiac troponin may also be an indicator of increased risk of postoperative myocardial infarction and mortality.
Other tests that may provide additional preoperative cardiac assessment include rest­ing echocardiograms, cardiac stress tests and CPET. The echocardiogram has not been shown to offer any advantage of reducing postoperative cardiac events over the basic clinical exam and overall patient assessment. Routine exercise stress testing is predictive of a good outcome if the patient can achieve more than 7 METS on the examination. In addition, areas of reversible ischemia are associated with increased cardiac risk. CPET has also been used as an objective measure of cardiac and pulmonary tness in some cen­ters but there is a lack of evidence to support routine use of these exams.
More objective parameters in the clinical evaluation may lead the surgeon to an in depth cardiac evaluation. These include a known history of coronary artery disease, heart failure, arrhythmias, and valvular heart disease. A myocardial infarction (MI) within 6 months of elective surgery is one of the most signicant risks of postoperative cardiac events. As the length of time between the MI and surgery increases, the risk of a postopera­tive cardiac event will decrease. Current guidelines suggest that non-urgent surgery should be delayed at least 60days after an MI if no coronary intervention has been per­formed. Symptomatic patients with valvular stenosis, particularly aortic stenosis, may also pose a signicant risk of cardiac events. Several scoring systems have been developed to quantify this risk. The American Society of Anesthesiologists (ASA) Score was devised in 1963. The ASA score is a subjective assessment of a patient’s overall health that is based on ve classes (I to V) (Table5.3).
Emergency surgery (E) is placed after the Roman numeral if the procedure being done requires that it be performed emergently.
5 Perioperative Assessment andRisk Stratication
41
Table 5.3 American Society of Anesthesiologists (ASA) Score
ASA I Patient is a completely healthy t patient. II Patient has mild systemic disease. III Patient has severe systemic disease that is not
incapacitating.
IV Patient has incapacitating disease that is a
constant threat to life.
V A moribund patient who is not expected to
live 24h with or without surgery.
These cases may pose greater risk to the patient but will not allow a more substantial preoperative evaluation due to the urgent nature of the case. Emergent cases should be done as safely as possible to allow for the best possible outcome. In these cases, patients should be given adequate uid resuscitation prior to surgery as well as proper prophylaxis with antibiotics and anticoagulation to pre­vent deep vein thrombosis. The rate of post­operative complications has been closely related to ASA classication with the more complicated patients (ASA IV) having a 23-fold rate of complications compared to the simpler (ASA I) patients. ASA however does have limitations. It does not account for the age, weight, sex, anesthesiologist or surgeon skill, pregnancy, or preoperative resuscitation of the patient undergoing surgery. In addition, the words “systemic disease” may not account for a recent myocardial infarction as it may instead represent a local disease.
The Revised Cardiac Risk Index (RCRI) (Table5.4) has been validated as a tool to pre­dict perioperative cardiac complications. This relatively simple scale may provide some insight into perioperative cardiac complica­tions. Glance and his colleagues developed the Surgical Mortality Probability Model (S-MPM) because many clinicians who use the Revised Cardiac Risk Index do not account for the non-cardiac causes that may account for perioperative mortality. Their 9-point 30-day mortality risk index includes ASA physical status (I—0 points, II—2 points, III—4 points, IV—5 points, V—6 points), emergent nature of the intended sur-
Table 5.4 Revised cardiac risk index
1. History of ischemic heart disease
2. History of congestive heart failure
3. History of cerebrovascular disease (stroke or transient ischemic attack)
4. History of diabetes requiring preoperative insulin use
5. Chronic kidney disease (creatinine >2mg/dl)
6. Undergoing supra-inguinal vascular, intraperitoneal, or intrathoracic surgery
Risk for cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest: 0 predictors=0.4%, 1 predictor=0.9%, 2 predictors=6.6%, 3 predictors=>11%
gery (1 point for emergent surgery), and sur­gery risk class (low—0 points, intermediate—1 point, or high—2 points). Point totals less than 5 were associated with a mortality of less than 0.5% while scores over 6 were associated with 10% mortality. The advantage of the S-MPM system is the rela­tive ease of calculation and use along with its validity.
E. Other Global Patient Assessment Tools
There have been many different patient assessment systems that have been devised to assess patient risk prior to surgery. The pur­pose of these tools is to allow the physician to provide proper informed consent for the upcoming surgical procedure, guide clinical decision making in the preoperative period, and thereby improve surgical outcomes. The many systems that are currently in use are quite varied. While some systems strictly make use of preoperative values, some use intraoperative data as well as postoperative variables that can all affect patient outcomes. The problem with adding intraoperative and postoperative variables is that they are of lit­tle value to the practicing physician when they are seeing a patient in the ofce prior to surgery and trying to provide guidance to the patient as to what tests or assessments the patient will require prior to the intended procedure.
The most common validated tools currently used for preoperative risk stratication include ASA-PS (Physical Status) (Table 5.3), the
42
D. G. Bakes and L. R. Sands
Surgical Risk Scale, the Surgical Risk Score, and the Charlson Comorbidity Index. The Surgical Risk Scale and the Surgical Risk Score both include the ASA-PS while they also con­sider the urgency and the severity of the intended surgical procedure. Tools that also consider intraoperative events and postoperative data include the Physiological and Operative Score for the enUmeration of Mortality and Morbidity (POSSUM) and the Portsmouth variation of POSSUM (P- POSSUM). Another tool, the Acute Physiology and Chronic Health Evaluation II (APACHE II) considers a measure of acute physiology and chronic health when evaluating patients as it also utilizes the patient’s physiologic results within the 24 h of critical care admission. Even more confusing is that some of these validated scoring systems, use subjective data such as the interpretation of chest X-rays, perhaps making the tools less effective.
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Surgical Risk Calculator is an instrument that employs 21 preoperative risk factors. This calculator allows a Surgeon Adjustment Score that can be modied by the physician’s clinical impression. While this scoring system can predict risk for many different surgical proce­dures, it can more specically predict the risk and complications including potential returns to the OR for 10 different CPT codes for lapa­rotomy. It has not been found to be as predic­tive in emergent situations.
An Apgar score has also been described for surgical procedures. This scoring system measures blood loss, the lowest heart rate and the lowest mean arterial pressure. It is based on a 10-point scale as the one used in child­birth for newborns. Scores less than or equal to 4 are associated with worse outcomes. The limitation to this scoring system is that it is only useful as a predictor after surgery and is not a valid tool to be used for preoperative risk assessment since its metrics are all based upon operative events. It too has a limited role in emergency procedures.
The Estimation of Physiologic Ability and Surgical Stress (E-PASS) scoring system was developed to account for patient’s reserve and surgical stress to calculate a morbidity and mortality. This system uses two parts to derive at a comprehensive score. The rst part uses a preoperative risk scoring system that accounts for age, the presence or absence of heart disease, pulmonary disease, diabetes, as well as a performance status index, while the second part uses a surgical stress scoring sys­tem which is calculated based upon the amount of blood loss, the patient’s body weight, the operative time, and the extent of the skin incision. As the comprehensive score rises, so does the complication and mortality rates. The E-Pass, while specically designed for gastrointestinal surgery, has yet to be vali­dated in large multicenter trials.
In summary, there are many risk stratica­tion scales and scores that have been devel­oped. The physician must decide which system best suits their practice so that they can properly inform their patients of the appropriate risks of surgery and guide them to the tests required so they may have the best clinical outcomes.
F. Risk Reduction Strategies
There have been several strategies pro­posed to help eliminate cardiac risk in those patients undergoing non-cardiac surgery. While many of the methods used today con­sist of medical therapy some have questioned the benets of undergoing prophylactic coro­nary artery bypass surgery prior to having elective major surgery. The CARP trial dem­onstrated no mortality reduction associated with the performance of prophylactic coro­nary artery bypass surgery in patients with stable coronary artery disease who were to undergo major elective vascular surgery. In addition, the DECREASE V trial did not show any additional reduction in death and MI undergoing coronary revascularization in high-risk vascular surgery patients with extensive stress-induced ischemia especially if tight heart rate control was also achieved with beta blockers.
5 Perioperative Assessment andRisk Stratication
43
In patients with bare metal stent place­ment, dual antiplatelet therapy (DAPT) should be continued for 4–6 weeks before non-cardiac surgery. If a drug eluting stent has been placed, DAPT should be continued for 6months, or a minimum of 3 months if the risk of delay exceeds the risk of an isch­emic event.
Perioperative beta-blocker usage is associ­ated with a lower incidence of non-fatal MI, but higher incidence of bradycardia, hypoten­sion, and stroke. The American College of Cardiology (ACC) recommends that beta­blockers should be continued in patients tak­ing them chronically. In addition, they suggest that beta blocker therapy should begin even one day prior to surgery in patients with car­diac ischemia or more than 3 cardiac risk indices (see Table5.4).
The benet of statins has also been called into question. Statins have been shown to sta­bilize plaques thereby preventing plaque rup­ture and thus lowering the risk of myocardial infarction. The American College of Cardiology recommends that statins be con­tinued in patients chronically taking them and to begin therapy for patients undergoing vas­cular surgery and those with other clinical indications such as diabetes, coronary artery disease, peripheral arterial disease and hyper­lipidemia while undergoing high-risk proce­dures (see Table5.1).
The decision to use aspirin must be made on a case-by-case basis weighing the risks of a cardiovascular event against the risks of perioperative bleeding. The POISE 2 trial compared those patients already on aspirin therapy to those who were aspirin naïve. There was no benet in terms of reducing MI or death but those on aspirin had an increased risk of bleeding with the highest risk seen in those started earlier on aspirin.
G. Special Considerations With the incidence of obesity on the rise and
more of these patients requiring surgery, we must consider certain aspects in the preopera­tive evaluation specic for this patient popula­tion. Once again, a careful history and physical
examination should be performed focusing on the presence or absence of sleep apnea and the need for spirometric studies in those with this condition. An EKG should be obtained if there are risk factors that mandate this exam. Fasting blood sugars should also be assessed to rule out metabolic syndromes.
Immunosuppressed patients are evaluated in the
same manner as those who are immuno­competent. If the patient is taking chronic ste­roids prior to surgery, then the patient should be given stress steroid dosing at the time of the surgery. Fasting blood sugar levels should also be monitored. While patients taking anti­TNF agents do not require additional pre­operative testing, they have been associated with a higher risk of postoperative infectious complications remote from the surgical site as well as overall complications and these patients should be counseled accordingly. If feasible, stopping anti-TNF 2months prior to surgery would be ideal to decrease this rate and improve postoperative outcomes.

Summary

While the majority of the preoperative evaluation is now undertaken by internists and anesthesiolo­gists in Preoperative Assessment Clinics (PAC), it remains the responsibility of the attending surgeon to ensure that the patients are properly counseled as to the operative risk for patients undergoing elective non-cardiac surgery. The surgeon needs to have a good understanding of the multitude of tests and stratication systems available preopera­tively to ensure patient safety for the best possible outcome. Risk reduction strategies should be con­sidered carefully and implemented whenever pos­sible for patients undergoing surgery.

Suggested Reading

Cohn S.Preoperative evaluation for non-cardiac surgery.
Ann Intern Med. 2016.
Cohn S.The cardiac consult for patients undergoing non-
cardiac surgery. Heart. 2016.
44
D. G. Bakes and L. R. Sands
Copeland GP, etal. POSSUM: a scoring system for surgi-
cal audit. Br J Surg. 1991;78:355–60.
Glance LG, et al. The Surgical Mortality Probability
Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012;255(4):696–702.
Hltaky MA, etal. A brief self-administered questionnaire
to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651–4.
Huddart S, etal. Use of a pathway quality improvement
care bundle to reduce mortality after emergency lapa­rotomy. Br J Surg. 2015;102(1):57–66.
Knaus WA, et al. APACHE—acute physiology and
chronic health evaluation: a physiologically based classication system. Crit Care Med. 1981;9:591–7.
Lee TH, etal. Derivation and prospective validation of a
simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Oka Y, et al. Usefulness of an estimation of physiologic
ability and surgical stress (E-PASS) scoring sys­tem to predict the incidence of postoperative com­plications in gastrointestinal surgery. World J Surg. 2005;29:1029–33.
Whiteley MS, etal. An evaluation of the POSSUM scor-
ing system. Br J Surg. 1996;83:812–5.
Wilson Tang WH, et al. Prognostic value of estimated
functional capacity incremental to cardiac biomarkers in stable cardiac patients. J Am Heart Assoc. 2014.
Enhanced Recovery Pathways inColorectal Surgery
SheriefShawki, DavidLiska, andConorP.Delaney
6

Introduction

The traditional model of perioperative patient man­agement relies on surgical, anesthesia, and other involved teams, providing care in a separate and individualized manner. The specic care provided depends on practice preferences of the various indi­vidual members of the healthcare teams involved. Collectively, this created signicant variation in patient care, which had the potential to lead to worse patient outcomes and increased health expenditures. Enhanced recovery pathways (ERPs), are standard­ized, multidisciplinary approaches to perioperative care designed to guide health care teams towards collaborative care, based on a combination of evidence- based interventions. The goal is to mini­mize the patient’s physiologic stress response to surgery and thereby allow for rapid recovery to baseline function. The different phases of perioper­ative care, including preoperative optimization, intraoperative care, and post-operative recovery are integrated into a single patient-centered pathway, allowing for decreased variability and costs, and improved outcomes. In colorectal surgery and in
S. Shawki Department of Colorectal Surgery, Mayo Clinic, Rochester, MN, USA
D. Liska · C. P. Delaney (*) Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA e-mail: delanc@ccf.org
many other disciplines, the efciency of patient care, accelerated recovery, and reduction in length of stay achieved by ERPs has been shown not to compromise patient safety or lead to an increase in readmission rates. An important component of ERPs, running parallel to these three phases of care, is an ongoing audit and evaluation of outcomes and value provided by the pathway. Figure 6.1 illus­trates the ow and different components of ERPs as described below.
A.Preoperative Management
Refer to Algorithm in Fig. 6.1
Patient Education andEngagement
In ERPs the patient is an integral part of the process and rather than being a passive recipient, is an active participant in their own recovery process. To man­age expectations, education of patients and their caregivers must start in the preoperative phase and should include a clear explanation of the periopera­tive care plan. Besides the traditional explanations regarding the disease, surgical plan, and risks asso­ciated with the surgery, patients should be provided with information about postoperative expectations, including daily goals/milestones regarding pain management, physical activity, and diet. Providing effective patient education is an acquired skill, and providing simple yet comprehensive materials is extremely helpful. The criteria for hospital dis-
© Springer Nature Switzerland AG 2020 S. R. Steele etal. (eds.), Clinical Decision Making in Colorectal Surgery,
https://doi.org/10.1007/978-3-319-65942-8_6
45
46
Fig. 6.1 Algorithm for enhanced recovery pathways for colorectal surgery
S. Shawki et al.
charge should also be explained during this phase as a way of setting realistic expectations for patients, emphasizing that their active involvement can improve outcomes. Establishing a good patient­healthcare team relationship and providing a solid method of communication can aid in developing patients’ trust in the process, reduce patient anxiety and may alleviate unnecessary readmissions.
Evaluation, Optimization, Nutrition andPrehabilitation
Modern practice of surgery views the patient as a whole, since other factors, beyond surgical tech­niques, can often signicantly contribute to patient outcomes. The principal goal of preopera­tive optimization is to target patients with preex­isting functional compromise in whom physiologic reserves can be improved to better withstand the stress of the planned surgery. Social and behavioral factors that can inuence recov­ery, such as illicit drug use, tobacco smoking, and alcohol dependency should also be addressed.
Poor nutritional status leads to increased sus­ceptibility to infection, poor wound healing, and is associated with worse postoperative outcomes including increased morbidity and length of stay (LOS). Therefore, malnutrition should always be
screened for in-patients undergoing colorectal surgery. Several validated tools can be used to identify poorly nourished patients preoperatively. One of which is the patient-generated Subjective Global Assessment (SGA) which assesses nutri­tional status based on features of the history and physical examination and categorizes patients into well nourished (SGA-A), moderately nour­ished (SGA-B), and severely malnourished (SGA-C). Nutritional optimization for 2–3weeks, preferably via the enteral route, has been shown to improve outcomes in malnourished patients. Recent studies have shown that perioperative intake of nutritional supplements enriched with arginine and sh oils (“immunonutrition”) can reduce the incidence of postoperative infectious complication, especially, in high risk patients. A recent meta-analysis of 27 randomized controlled trials assessing the role of immunonutrition in patients undergoing surgery for gastrointestinal malignancies found that perioperative enteral immunonutrition signicantly reduced the inci­dence of postoperative infectious complications when compared to with standard enteral nutrition (RR, 0.46; 95% CI, 0.34–0.62).
The body’s capacity to compensate for the
stress induced by surgery relies on its physio-
6 Enhanced Recovery Pathways inColorectal Surgery
47
logical reserve. Frailty, dened as globally reduced physiologic reserve, is frequently pres­ent in the elderly or other patients who harbor multisystem impairment, or are functionally deconditioned at baseline. These patients are at increased risk for postoperative complications, and prolonged recovery and LOS. Prehabilitation is a structured process aiming at increasing patients’ physiological reserve in anticipation of an upcoming stressor and thereby reduce post­operative morbidity and accelerate recovery. There are several different assessments and indices available to help measure the degree of frailty for risk stratication. The 11-variable modied Frailty Index (mFI) is one such tool that, based on the patient’s baseline functional status and comorbidities, identies those who could benet from preoperative prehabilitation. The mFI assigns a score from 0 to 11, with a score of 0 signifying the absence of frailty, whereas a score of 11 equals maximum frailty. Recent studies demonstrated that about 61% of postoperative patients with mFI of 0–1 (an increase in the mFI score implies increased frailty) spent 1–3 days in the hospital, while more than 50% of patients with mFI of 3 or more were hospitalized between 4 and 8days. Further studies suggest that a 4-week period of prehabilitation can improve walking capacity in colorectal cancer patients, with deconditioned patients making the biggest gains. However, these functional gains have not yet been shown to lead to improved perioperative outcomes and further studies are needed.
Preoperative optimization also extends to include disease-specic and lifestyle modica­tions in patients with comorbidities such as dia­betes mellitus, chronic obstructive lung disease and congestive heart failure. Occasionally, opti­mization by a specialist is recommended. Smoking also imposes risks to postoperative pul­monary status, incisional healing and anasto­motic integrity. One study found that patients who underwent smoking cessation at least 4 weeks prior to surgery had better outcomes than a reference cohort of patients that did not participate in cessation programs. Similarly, increased alcohol consumption (>3ETOH units/
day) been associated with increased complica­tions, and preoperative alcohol cessation may result in decreased complications.
Additional data is needed to justify the allo­cation of resources toward creation of a struc­tured program that combines preoperative exercise training, nutritional support, and opti­mization of chronic disease processes, although such a practice appears rational for preoperative optimization.
Mechanical Bowel Preparation andOral Antibiotics
The role of mechanical bowel preparation (MBP) in reducing intra- and post-operative complica­tions in colon and rectal surgery had been an area of debate with multiple prospective studies show­ing no difference in outcomes when MBP is used. However, many of these trials did not include oral antibiotics. In U.S clinical trials, mechanical bowel preparation combined with oral antibiotics has consistently been found to decrease infec­tions rates. Furthermore, with mechanical bowel preparation intraoperative laparoscopic manipu­lation of the bowel, specimen extraction through small incisions, and performing stapled anasto­moses is easier and less traumatic. It is therefore our practice for all colorectal resections to rou­tinely prescribe preoperative mechanical bowel preparation in combination with oral antibiotics consisting of neomycin and metronidazole.
Reduction ofPre-operative Fasting andCarbohydrate Loading
Traditional preoperative preparation included patient fasting after midnight on the day of surgery, to reduce the risk of aspiration during the induction of anesthesia. This resulted in a prolonged period of time for the patient without hydration or nutri­tion. Mechanical bowel preparation, with the resulting diarrhea and uid shifts, can further increase the risk for dehydration in these patients that can in turn lead to hypotension upon induction of anesthesia due to vasodilation. Furthermore, thirst and hunger, rank among the most common complaints patients have before surgery. Studies have shown that the intake of clear uids up to 2h before surgery does not increase gastric volumes
48
S. Shawki et al.
and the risk for aspiration in patients without underlying gastroparesis. Therefore, current anes­thesia guidelines prohibit solid food intake for 6h before elective surgery, but encourage clear liquid intake until 2h before surgery. Recent studies have evaluated the effect of oral supplementation with carbohydrate rich drinks before surgery on the patient’s postoperative met­abolic state. Several studies have shown that car­bohydrate loading prior to elective surgery, by administration of a complex carbohydrate- rich drink (100 mg the evening before surgery and 50g 2–3 h prior to anesthesia), increases insulin sensitivity. Insulin resistance is a recognized risk factor for the development of postoperative com­plications. While physiological data supports the concept of carbohydrate loading, it is not yet clear if reducing insulin resistance in turn results in improved clinical outcomes such as decreased postoperative complications and LOS.Thus, fur­ther investigation is needed to better dene the role of preoperative carbohydrate loading, and whether there is any improvement over placebo. However, irrespective of the proposed benets on postoperative outcomes, preoperative carbohy­drate loading may also decrease anxiety, and reduce hunger and thirst while waiting for sur­gery, thereby improving patient satisfaction.
B.Intraoperative Care
Minimally Invasive Colorectal Surgery
While laparoscopic colorectal surgery and ERPs result in improved outcomes independently, there is a synergistic effect when both are combined together resulting in the shortest hospital stay, averaging 2.6days, with some patients being dis­charged within 24h. Other benets include faster regain of bowel motility, earlier tolerance of solid oral intake and having bowel function. A Cochrane review of 3RCTs and 6control studies conrmed the above mentioned outcomes with­out an increase in patient morbidity. Reduction in hospital stay and early discharge did not have an
impact on readmission rate. The laparoscopic approach has also been shown to reduce the risk of infectious complications. It is now well estab­lished that minimally invasive surgery results in improved perioperative outcomes and acceler­ated recovery from surgery. Prospective random­ized controlled trials have also shown that, in colon cancer surgery, long term oncologic out­comes are similar between the laparoscopic and open approach. Due to inconclusive results of recent trials examining the role of laparoscopy in rectal cancer, the optimal approach to rectal can­cer is still a matter of debate. However, in experi­enced hands with documented good oncologic outcomes, the laparoscopic approach in rectal cancer has also been shown to improve early postoperative outcomes and accelerate recovery.
Intraoperative Fluid Administration
Perioperative uid homeostasis is inuenced by surgical stress induced hormonal changes. Historically, uid resuscitation was based on often overestimated requirements, which trans­lated into early postoperative weight gain sec­ondary to uid retention and third spacing. In elective bowel surgery, uid overload of as little as 3L may result in increased complication rates and a narrow range uid balance should be the goal (indicated by minimal weight gain on POD1; <2.5kg). Restrictive uid resuscitation strategies have demonstrated a decrease in cardiopulmo­nary complications and LOS (as few as 2.7days) without an adverse effect on anastomotic leakage or surgical-specic complications. Prolonged fasting and bowel preparation should be consid­ered during resuscitation due to the associated uid decits. Intra-operatively, identifying patients’ needs based on indices reecting real­time volume status can assist in tailoring intraop­erative uid resuscitation that minimizes uid overload. Tools such as transesophageal probes, central venous catheters, and nger probes can use circulatory parameters as surrogates of real­time volume status to guide volume repletion. The use of invasive tools should be selective and
6 Enhanced Recovery Pathways inColorectal Surgery
49
the cost of newer non-invasive cardiac output measuring tools still needs to be justied by evi­dence demonstrating improved outcomes. The current state of the literature would suggest that goal-directed uids tend to improve outcomes when the control group has neither goal-directed uids, nor an event related potentials (ERP). Trials comparing goal-directed uids vs placebo in patients on enhanced recovery pathways for intestinal surgery tend to show no improvement with GDFT.Similarly, postoperatively, the use of maintenance intravenous uids should be judi­cious and based on objective indices including, but not limited to, urinary output, serum creati­nine, and blood urea nitrogen.
Analgesia
In ERPs pain control is envisioned as one con­tinuum rather than separate pre-, intra- and post­operative phases. The goal is to achieve adequate postoperative pain control to accomplish daily activity milestones such as ambulation and deep breathing while minimizing the development of adverse effects, such as nausea, vomiting, ileus, hypotension, and/or kidney injury, among oth­ers. It is often helpful to discuss and review the proposed postoperative regimen and set appro­priate expectations prior to surgery. For better efcacy, pain control should start during the perioperative phase. Suppressing nociceptors prior to surgical pain stimulus has been shown to reduce postoperative narcotic requirements. This “preemptive” analgesia includes a spec­trum of analgesia ranging from oral medications starting the day prior to surgery, to neuroaxial blockade via placement of epidural catheter, or spinal analgesia prior to the procedure, to local inltration of surgical sites prior to incision as in laparoscopic surgery. Non-steroidal anti­inammatory drugs (NSAIDs) such as ibupro­fen, ketorolac, or celecoxib are administered on the day of surgery. Acetaminophen and gaba­pentin are both given in the preoperative stage. Peripheral nerve blockade using transverse abdominis muscle plane (TAP) block have
shown to decrease postoperative opioid usage without many of the side effects associated with epidural analgesia. It is a technically simple, easy to learn, low-cost procedure and can easily be performed under laparoscopic or ultrasound guidance. In our practice, we have not favored the use of epidurals, as there is no clear evidence of them helping in the setting of an enhanced recovery pathway, and two randomized trials we have performed and several meta- analyses show no improvement.
Multimodal pain control regimens should be tailored towards each patient based on patients’ history of chronic narcotics usage, liver and kid­ney function, age, and type of surgery.
Venous Thromboembolism Prophylaxis
According to Surgical Care Improvement Project (SCIP) guidelines pharmacological venous thromboembolism (VTE) prophylaxis should be given within 24h of surgery, and it is our practice to administer 5000units of unfractionated hepa­rin prior to induction, in addition to the use of sequential compression devices (SCD). Mechanical and pharmacological VTE prophy­laxis is routinely continued postoperatively until discharge. Early post-operative mobilization has been shown to dramatically reduce the incidence of VTEs. Both unfractionated heparin and low molecular weight heparin (LMWH) can be used with data showing no signicant difference between both prophylactic agents. When epidural catheters are used for analgesia, timing of the administration of heparin needs to be coordinated to minimize the risk of bleeding during place­ment and removal of the catheter. Current guide­lines recommend extending postoperative VTE chemoprophylaxis for up to 4weeks in high risk individuals such as cancer patients undergoing major abdominopelvic surgery. Other high risk conditions that may benet from extended VTE prophylaxis include morbid obesity, limited mobility, history of prior VTE or PE, and possi­bly inammatory bowel disease. Patients going